GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Durata Therapeutics Inc (FRA:DTA) » Definitions » Sale Of Business

Durata Therapeutics (FRA:DTA) Sale Of Business : €0.00 Mil (TTM As of Sep. 2014)


View and export this data going back to . Start your Free Trial

What is Durata Therapeutics Sale Of Business?

Durata Therapeutics's sale of business for the three months ended in Sep. 2014 was €0.00 Mil. It means Durata Therapeutics gained €0.00 Mil from selling business. Durata Therapeutics's sale of business for the trailing twelve months (TTM) ended in Sep. 2014 was €0.00 Mil.

Compared with last quarter (€0.00 Mil in Jun. 2014 ), Durata Therapeutics gained the same money from selling business in Sep. 2014 (€0.00 Mil).


Durata Therapeutics Sale Of Business Historical Data

The historical data trend for Durata Therapeutics's Sale Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Durata Therapeutics Sale Of Business Chart

Durata Therapeutics Annual Data
Trend Dec11 Dec12 Dec13
Sale Of Business
- - -

Durata Therapeutics Quarterly Data
Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14
Sale Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Durata Therapeutics Sale Of Business Calculation

The amount earned to sell business.


Sale Of Business for the trailing twelve months (TTM) ended in Sep. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Durata Therapeutics Sale Of Business Related Terms

Thank you for viewing the detailed overview of Durata Therapeutics's Sale Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.


Durata Therapeutics (FRA:DTA) Business Description

Traded in Other Exchanges
N/A
Address
Durata Therapeutics Inc was incorporated under the laws of the State of Delaware on November 4, 2009. The Company, along with its subsidiaries, is a development stage pharmaceutical company focused on the development and commercialization of novel therapeutics for patients with infectious diseases and acute illnesses. The Company recently completed two global Phase 3 clinical trials with its lead product candidate, dalbavancin, for the treatment of patients with acute bacterial skin and skin structure infections, or ABSSSI. Dalbavancin is an intravenous antibiotic product candidate designed for once-weekly dosing.

Durata Therapeutics (FRA:DTA) Headlines

No Headlines